Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell Therapy

Authors: Metin Özdemirli, Thomas Loughney, Emre Deniz, Joeffrey Chahine, Maher Albitar, Stefania Pittaluga, Sam Sadigh, Philippe Armand, Aykut Uren, Kenneth C. Anderson - New England Journal of Medicine, NEJM 2024 cited by 90

gene. In addition, numerous genetic alterations that may have contributed to malignant transformation were identified in the tumor sample. (Funded by MedStar Georgetown University Hospital.).